Gluskin Sheff & Assoc Inc Astrazeneca PLC Transaction History

Gluskin Sheff & Assoc Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $200,430 - $242,490	3,000 Added 10.05%	32,840 $2.56 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $579,785 - $660,914	9,500 Added 46.71%	29,840 $2.02 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $522,970 - $585,416	-8,450 Reduced 29.35%	20,340 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $649,797 - $718,434	-10,020 Reduced 25.82%	28,790 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $1.75 Million - $1.9 Million	25,010 Added 181.23%	38,810 $2.78 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $871,470 - $988,079	13,800 New	13,800 $957,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.